Cargando…
Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators
As a live biologic agent, oncolytic vaccinia virus has the ability to target and selectively amplify at tumor sites. We have previously reported that deletion of thymidine kinase and ribonucleotide reductase genes in vaccinia virus can increase the safety and efficacy of the virus. Here, to allow di...
Autores principales: | Gallardo, Franck, Schmitt, Doris, Brandely, Renée, Brua, Catherine, Silvestre, Nathalie, Findeli, Annie, Foloppe, Johann, Top, Sokunthea, Kappler-Gratias, Sandrine, Quentin-Froignant, Charlotte, Morin, Renaud, Lagarde, Jean-Michel, Bystricky, Kerstin, Bertagnoli, Stéphane, Erbs, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760631/ https://www.ncbi.nlm.nih.gov/pubmed/33256205 http://dx.doi.org/10.3390/biomedicines8120543 |
Ejemplares similares
-
Oncolytic properties of non-vaccinia poxviruses
por: Ricordel, Marine, et al.
Publicado: (2018) -
Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
por: Ricordel, Marine, et al.
Publicado: (2018) -
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
por: Foloppe, Johann, et al.
Publicado: (2019) -
Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus
por: Myers, Rachel, et al.
Publicado: (2016) -
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs
por: Béguin, Jérémy, et al.
Publicado: (2021)